The funding will help Sweetch Health enhance its platform to provide users with bespoke recommendations. Here are the top-line bullets you need to know.
Sweetch Health, a chronic condition management platform, has raised $20M in Series A. The round drew participation from Noaber Foundation, Kortex Ventures, Entree Capital, and FinTLV, among others.
HOW’S THE COMPANY PERFORMING?
- Israel-based Sweetch Health leverages AI to treat people with chronic diseases, like heart disease, diabetes, obesity, hypertension, rheumatoid arthritis, and inflammatory bowel disease. It offers users with personalized recommendations to help manage their chronic conditions.
- The app was chosen as one of 5, from over 400 prospects, to join the Bayer G4A program, a healthcare accelerator.
WHY DOES THE MARKET MATTER?
- The digital health market is projected to grow at a CAGR of 28.5% to reach a value of $639B by 2026, according to Global Market Insights.
- In Q2’21, global healthcare investment rose for the seventh consecutive quarter, albeit at a slower pace. Funding surpassed $34.7B across nearly 1.6K deals.